Efficacy of CDK 4/6 inhibition after fulvestrant in metastatic breast cancer

Authors :: E. Van Limbergen
Sileny Han
R Salihi
Ignace Vergote
H. Wildiers
Patrick Berteloot
K Punie
A Smeets
Benoit Beuselinck
I. Lefever
Hilde Janssen
G Hoste
Patrick Neven
Caroline Weltens
Ines Nevelsteen
E Van Nieuwenhuysen
Nicole Concin
Source :: European Journal of Cancer. 92:S111-S112
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Cancer Research
Oncology
biology
Fulvestrant
business.industry
Cyclin-dependent kinase
biology.protein
Cancer research
Medicine
business
medicine.disease
Metastatic breast cancer
medicine.drug

Tools